Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Granted US Patent for miRNA Used in Diagnostic Tests

Premium

Rosetta Genomics said this week that the US Patent and Trademark Office has issued US Patent No. 7,943,745, covering the composition of matter for human hsa-miR-497 and its variants.

The patent is not yet listed in the USPTO database.

Rosetta said that human hsa-miR-497 is an "important component" of its miRview Mets and miRview Mets2 diagnostic tests, used to identify the tissue of origin in cancers of unknown primary.

Earlier this month, the company launched a US-based oncology sales team for these test (GSN 5/5/2011).

The new patent adds to 21 patents and more than 105 patent applications in the company's intellectual property portfolio.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.